Bisphosphonates vs infliximab in ankylosing spondylitis treatment.
about
Influence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis.Spinal Compression Fracture Management: A Review of Current Treatment Strategies and Possible Future Avenues.Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis.Focal bone involvement in inflammatory arthritis: the role of IL17.Pharmacological therapy of spondyloarthritis.Osteoporosis Management in Ankylosing Spondylitis.Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis.Effect of golimumab and pamidronate on clinical efficacy and MRI inflammation in axial spondyloarthritis: a 48-week open randomized trial.A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis
P2860
Q33584246-13058E79-86E8-4111-88CD-DAE7E650B72CQ33590002-678FD2B0-8029-4E82-AF90-723A5A2A5916Q38198090-AFC1B741-C721-496B-A0D1-BB0259C63687Q38295616-738283AD-2D86-47A9-96AE-0B51B57F2261Q38527552-84B7D869-FF64-452C-9AEA-39E4091A78F0Q38670399-9E4033FD-9A01-44CE-8075-54C4B2D321E4Q38972623-4E741D18-D7C4-4FC3-A978-CC8E2F3ACA11Q39135959-D597F40E-1B5E-4F4D-9828-EE2263B7F1A7Q41067642-08017E25-64E0-4D35-B1D4-E333129DC23AQ42332209-C221DEEB-EDA9-4EDF-A8AE-ACDD2528423CQ53380550-89AA3238-2696-46FA-92D4-B4C3C3AE4849Q57623434-C9039649-BD0B-4EE8-921E-0E15C6BEF2B0
P2860
Bisphosphonates vs infliximab in ankylosing spondylitis treatment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Bisphosphonates vs infliximab in ankylosing spondylitis treatment.
@en
Bisphosphonates vs infliximab in ankylosing spondylitis treatment.
@nl
type
label
Bisphosphonates vs infliximab in ankylosing spondylitis treatment.
@en
Bisphosphonates vs infliximab in ankylosing spondylitis treatment.
@nl
prefLabel
Bisphosphonates vs infliximab in ankylosing spondylitis treatment.
@en
Bisphosphonates vs infliximab in ankylosing spondylitis treatment.
@nl
P2093
P50
P356
P1433
P1476
Bisphosphonates vs infliximab in ankylosing spondylitis treatment
@en
P2093
Elena Fracassi
Maria Rosaria Povino
Ombretta Viapiana
Silvano Adami
Sonila Troplini
P356
10.1093/RHEUMATOLOGY/KET321
P577
2013-09-24T00:00:00Z